Clinical Trial Update: A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System [Phase 4]

View source ↗

Summary

Phase 4 post-marketing trial comparing fidaxomicin versus vancomycin for sustained cure of Clostridium difficile infection in immunosuppressed adults; study ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Fidaxomicin (fidaxomicin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Clostridium Difficile | Phase 4 | Status: TERMINATED